NewsBenzinga更新:Tarsus Pharmaceuticals、第3四半期調整後EPSは▲0.78ドルで、予想の▲2.73ドルを上回る。売上高は1億9,456.9万ドルで、予想の1億8,659.8万ドルを上回る。 更新:Tarsus Pharmaceuticals、第3四半期調整後EPSは▲0.78ドルで、予想の▲2.73ドルを上回る。売上高は1億9,456.9万ドルで、予想の1億8,659.8万ドルを上回る。 Benzinga 2026.11.03 23:05 (GMT+0) Open on Benzinga Other news How Tokenized Nvidia Traded Through Two Weeks of Huang Headlines What Are Wall Street Analysts' Target Price for Lumentum Holdings Stock? Texas Pacific Land Stock: Analyst Estimates & Ratings Keybanc Reiterates Sector Weight on NVIDIAto Sector Weight Top 3 Tech Stocks That May Fall Off A Cliff This Month Truist Securities Maintains Hold on BILL Holdings, Raises Price Target to $66